1986
DOI: 10.1002/hup.470010206
|View full text |Cite
|
Sign up to set email alerts
|

L‐Tryptophan and prolactin release: Evidence for interaction between 5‐HT1 and 5‐HT2 receptors

Abstract: The effects of the selective 5-HT2 receptor antagonist, ritanserin, on the growth hormone (GH) and prolactin (PRL) responses to intravenous L-tryptophan (LTP) were assessed in 8 normal volunteers. Administration of ritanserin (40 mg orally) prior to infusion of LTP (5 g) significantly enhanced the PRL responses but not those of GH. The results are consistent with previous proposals that the endocrine responses to LTP are mediated by 5-HT1 rather than 5-HT2 receptors and also suggest that 5-HT2 receptor antagon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
15
0

Year Published

1987
1987
2005
2005

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(16 citation statements)
references
References 23 publications
1
15
0
Order By: Relevance
“…Binding properties of the receptor for the agonist depend upon the equilibrium that exists among the different states. GC-dependent inhibition of Gi production moves the equilibrium toward states 4-6, resulting in a reduction of 5-HT1A receptor-effector system function in FH rats further supports the hypothesis of a differential, presumably inversely directed, regulation of 5-HT1A and 5-HT2 receptors (Charig et al, 1986;Backus etal., 1989;Glennon etal., 1990;Kucharik etal., 1990). Since GC appear to have no effect on Go-protein expression, relative 5-HT2-Go-PI complex supersensitivity may prevail despite or as a consequence (by down regulating 5-HT1A function) of increased baseline cortisol secretion, thus maintaining HPA hyperactivity in depression.…”
Section: Differential Regulation Of 5-htia and 5-ht 2 Receptorssupporting
confidence: 50%
See 1 more Smart Citation
“…Binding properties of the receptor for the agonist depend upon the equilibrium that exists among the different states. GC-dependent inhibition of Gi production moves the equilibrium toward states 4-6, resulting in a reduction of 5-HT1A receptor-effector system function in FH rats further supports the hypothesis of a differential, presumably inversely directed, regulation of 5-HT1A and 5-HT2 receptors (Charig et al, 1986;Backus etal., 1989;Glennon etal., 1990;Kucharik etal., 1990). Since GC appear to have no effect on Go-protein expression, relative 5-HT2-Go-PI complex supersensitivity may prevail despite or as a consequence (by down regulating 5-HT1A function) of increased baseline cortisol secretion, thus maintaining HPA hyperactivity in depression.…”
Section: Differential Regulation Of 5-htia and 5-ht 2 Receptorssupporting
confidence: 50%
“…Although there appears to be a general agreement that 5-HT stimulates the release of prolactin, the subtype(s) of 5-HT receptor(s) involved remains unknown (Charig et al, 1986;Di Renzo et al, 1989). Since a presynaptic 5-HT deficiency may conceal altered postsynaptic 5-HT receptor sensitivity and since 5-HT2 (and 5-HTlc ) receptors have been implicated to participate in the mediation of prolactin release induced by agents which increase presynaptic 5-HT release (Gartside and Cowen, 1990), evidence for altered 5-HT2 receptor sensitivity remains mixed but there are positive indications to warrant continued study.…”
Section: -Ht Challenge Paradigmmentioning
confidence: 98%
“…The increase in plasma cortisol and prolactin following 5-HTP administration in man is modulated by at least three different postsynaptic receptors, the 5-HT1A, 5-HT2A, 5-HT2C, and 5-HT3 receptors (Meltzer and Maes, 1994;Meltzer et al, 1997). Pretreatment with pindolol, a 5-HT1A partial antagonist, significantly inhibited the prolactin, but not the cortisol response to 5-HTP (Meltzer and Maes, 1994), whereas ritanserin, a 5-HT2A/5-HT2C antagonist, did not block the prolactin response to tryptophan (Deakin, 1996) and even increased it in another study (Charig et al, 1986). However, it is not known whether neuroendocrine and antipanic effects of 5-HTP are mediated via the same 5-HT receptors.…”
Section: Challenge Studiesmentioning
confidence: 92%
“…The 5-HT2 agonists usually elicit a rise in blood pressure, without reliable in¬ creases in HR.56·57 In contrast, 5-HT1A agonists gener¬ ally produce a drop in blood pressure, again without consistent HR effects 38. …”
mentioning
confidence: 99%